Intracellular Pathogen Leishmania donovani Activates Hypoxia Inducible Factor-1 by Dual Mechanism for Survival Advantage within Macrophage by Singh, Amit Kumar et al.
Intracellular Pathogen Leishmania donovani Activates
Hypoxia Inducible Factor-1 by Dual Mechanism for
Survival Advantage within Macrophage
Amit Kumar Singh, Chaitali Mukhopadhyay, Sudipta Biswas, Vandana Kumari Singh,
Chinmay K. Mukhopadhyay*
Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, India
Abstract
Recent evidence established a crucial role for mammalian oxygen sensing transcription factor hypoxia inducible factor-1
(HIF-1) in innate immunity against intracellular pathogens. In response to most of these pathogens host phagocytes
increase transcription of HIF-1a, the regulatory component of HIF-1 to express various effector molecules against invaders.
Leishmania donovani (LD), a protozoan parasite and the causative agent of fatal visceral leishmaniasis resides in
macrophages within mammalian host. The mechanism of HIF-1 activation or its role in determining the fate of LD in
infected macrophages is still not known. To determine that J774 macrophages were infected with LD and about four-fold
increase in HIF-1 activity and HIF-1a expression were detected. A strong increase in HIF-1a expression and nuclear
localization was also detected in LD-infected J774 cells, peritoneal macrophages and spleen derived macrophages of LD-
infected BALB/c mice. A two-fold increase in HIF-1a mRNA was detected in LD-infected macrophages suggesting
involvement of a transcriptional mechanism that was confirmed by promoter activity. We further revealed that LD also
induced HIF-1a expression by depleting host cellular iron pool to affect prolyl hydroxylase activity resulting in to
stabilization of HIF-1a. To determine the role of HIF-1 on intracellular LD, cells were transfected with HIF-1a siRNA to
attenuate its expression and then infected with LD. Although, initial infection rate of LD in HIF-1a attenuated cells was not
affected but intracellular growth of LD was significantly inhibited; while, over-expression of stabilized form of HIF-1a
promoted intracellular growth of LD in host macrophage. Our results strongly suggest that LD activates HIF-1 by dual
mechanism for its survival advantage within macrophage.
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Introduction
The oxygen sensing transcription factor hypoxia-inducible
factor-1 (HIF-1) is a heterodimer of regulatory subunit HIF-1a
and constitutive HIF-1b [1]. In oxygen deficiency or cellular iron
depletion, expression of HIF-1a is regulated by a post-translational
protein stability mechanism mediated by a family of prolyl
hydroxylases (PHDs) [2]. HIF-1a subunit has a very short half-life
(,2 min) because it is targeted by an oxygen-dependent mecha-
nism to the proteasome by the von Hippel-Lindau (VHL) E3
ubiquitin ligation [3]. The recognition of HIF-1a by VHL
depends on hydroxylation of two proline residues (pro402 and
pro564) by three HIF-1a prolyl hydroxylases (PHD1-3) but PHD2
was found as the primary isoform responsible for this hydroxyl-
ation mechanism [4–6]. In general, PHDs hydroxylate HIF-1a
using oxygen and 2-oxoglutarate as substrates and iron and
ascorbate as essential cofactors [6,7]. Upon exposure to hypoxia or
iron depletion PHD activity is affected resulting into stabilization
of HIF-1a, which in turn translocates to the nucleus and forms
a dimer with HIF-1b to activate HIF-1. Once activated, HIF-1
binds to the hypoxia response elements (HREs) of target genes
implicated in metabolism, angiogenesis, apoptosis and cellular
stress [8]. Recent evidences suggest that HIF-1 plays a novel and
important role in infections and inflammatory diseases [9,10].
HIF-1 activation was reported to be essential for bactericidal
capacity of phagocytes by producing several immune effector
molecules for host defense [11]. In fact, HIF-1 activation was
reported as a general phenomenon in infections with human
pathogens [12]. In response to pathogens, HIF-1 expression is
upregulated through pathways involving key immune response
regulator NFkB [10]. Lipopolysaccharide (LPS), the bacterial
membrane component of gram negative bacteria activates HIF-1
in macrophages by NFkB dependent transcriptional mechanism
[13,14]. Interestingly, the basal expression of HIF-1a is also
regulated by NF-kB [15] and this evolutionary conserved link
between NF-kB and HIF-1 provides a strong innate immunity
mechanism to phagocytes against invading pathogens [10,15,16].
Leishmania donovani (LD), a digenetic protozoan parasite infects
and resides within macrophages during its mammalian cycle of
existence resulting into visceral leishmaniasis (VL). VL might be
fatal if not treated properly and was reported to cause mortality in
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e38489Figure 1. LD activates HIF-1 in macrophages in vitro. A. J774 cells were transfected either with wild type HRE or mutated HRE and b-
galactosidase constructs. After 16 h of infection with LD (MOI-1:10, macrophage: LD) luciferase activity in cell extracts was measured and normalized
with b-galactosidase activity. Results are represented as SD of 3 independent experiments performed in triplicate. B. Western blot analyses for HIF-1a
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also detected as coinfection in HIV patients [17]. After successful
entry into macrophages, promastigote form of the parasite survives
and proliferates within the mature phagolysosome compartment as
an amastigote, multiplies within and finally burst the host to infect
neighboring macrophages [18]. During its stay within parasito-
phorous vacuoles (PV) of macrophages, parasite scavenges
nutrients from the host cell, prevents host cell apoptosis, and
alters host cell gene expression [19]. Therefore, leishmania has
developed mechanisms to manipulate host cell processes that
permit the parasite to grow within hostile environment within host
macrophages. Recently, expression of HIF-1a is reported in L.
amazonensis infected skin lesions by immunocytochemistry [20,21]
but its role in controlling leishmanial infection or its mechanism of
activation remains to be resolved.
The goal of this work is to determine the mechanism by which
LD increases HIF-1a protein level and to find that whether HIF-1
is beneficial or detrimental to the invading parasite. We reveal the
involvement of HIF-1a transcription and protein stability
mechanisms in HIF-1 activation in LD infected macrophages.
We also report that HIF-1 activation is advantageous for survival
and growth of the parasite within host macrophage as knocking
down of HIF-1a by specific siRNA affects intracellular survival
and growth of the parasite. Other way, over-expression of
stabilized form of HIF-1a promotes growth of intracellular LD
suggesting a pivotal role of HIF-1 in benefiting intracellular
pathogen LD.
Results
Activation of HIF-1 in Macrophages by LD Infection
To determine the influence of LD infection on HIF-1 activation,
J774 macrophages were transfected with an active HRE driven
luciferase construct (CpHRE) [22] and then infected with virulent
LD (MOI-1:10). About four fold increase in luciferase activity was
detected by LD infection (Fig. 1A). However, transfection of
a mutant HRE-luciferase construct (mut-CpHRE) [22] showed no
change in luciferase activity (Fig. 1A) suggesting LD-infection
resulted in HIF-1 activation in J774 macrophages. Western blot
analysis was performed with nuclear extracts isolated from LD-
infected J774 cells to confirm that HIF-1 activation was actually
because of increased expression of HIF-1a. A steady increase up to
about 4-fold in HIF-1a protein level was detected with increased
multiplicity of infection of LD (Fig. 1B). A strong increase of HIF-
1a was detected within 8 h of infection that remained increased
even after 24 h of infection but expectedly no change in HIF-1b
was detected (Fig. 1C). To determine whether internalization of
LD was required for increased HIF-1a expression cytochalasin D
was used to block parasite internalization by phagocytosis as
described earlier [23]. Initially we confirmed the ability of
cytochalasin D (2 mM) to block internalization of LD in J774
macrophages (data not shown). In a similar condition we detected
a complete blocking of HIF-1a expression in J774 cells when
incubated with LD (Fig. 1D). In a complimentary experiment
conditioned medium of parasite was incubated with J774
macrophages to detect whether any soluble factor released by
the parasite was responsible for HIF-1a expression in host. No
change in HIF-1a expression was detected by conditioned
medium of the parasite (data not shown). Together these results
strongly suggest that internalization of LD is necessary for
increased HIF-1a expression in host macrophages. To further
detect the effect of LD-infection on nuclear localization of HIF-1a
of the host macrophages, indirect immunofluorescence assay was
performed in J774 and peritoneal macrophages isolated from
BALB/c mice (Fig. 2A & 2B). Results showed a strong nuclear
localized HIF-1a only in LD-infected macrophages. This was best
depicted in Fig. 2A showing the cell not infected with LD (bigger-
horizontal white arrow in lower panel) did not show nuclear
localization of HIF-1a, while other two adjacent cells infected with
LD (small white arrows) were detected with nuclear localized HIF-
1a. This result further suggests that LD does not produce any
soluble factor for HIF-1a expression as described earlier. A similar
result was also obtained in LD-infected RAW 264.7 macrophages
(data not shown). To further confirm that LD-infection promotes
HIF-1 during in vivo infection, macrophages were isolated from LD
infected BALB/c mice and prominent nuclear localized HIF-1a
immunofluorescence was detected in LD-infected macrophages
(Fig. 2C). Further, increased expressions of several HIF-1 target
genes like VEGF, GLUT-1 and PAI-1 were detected in
macrophages isolated from LD-infected BALB/c mice than
uninfected mice by real-time RT-PCR (Fig. 2D). These experi-
ments suggest LD activates HIF-1 in host macrophages both in vivo
and in vitro conditions.
LD Infection Increases HIF-1a mRNA and Protein Stability
in Macrophages
Bacterial infection and LPS treatment increase HIF-1a expres-
sion by promoting transcription of HIF-1a; whereas, other
inducers of HIF-1 like hypoxia, iron depletion or cobalt stabilize
HIF-1a protein by decreasing prolyl hydroxylase activity [4,5]. To
determine whether any of these mechanisms was responsible for
LD-induced activation of HIF-1, J774 cells were infected with LD
and Northern blot analysis was performed. LPS was used as
a positive control. About 2 fold increase in HIF-1a mRNA was
detected by LD infection (Fig. 3A) indicating HIF-1a mRNA
expression was at least partially responsible for LD-induced HIF-1
activation. An increase in HIF-1a mRNA was also observed by
real-time RT-PCR in macrophages isolated from LD-infected
mice (Fig. 3B) confirming this mechanism is also operative during
in vivo infection. To confirm the involvement of transcriptional
mechanism, we cloned HIF-1a promoter in pGL3-basic vector
upstream of luciferase gene, transfected into cells and performed
luciferase assay after LD infection or LPS treatment. Simulta-
neously, b-galactosidase under the control of SV40 promoter [24]
was cotransfected to monitor transfection efficiency. About 2 fold
increase in luciferase activity by LD infection confirmed the
involvement of HIF-1a transcription for HIF-1 activation in host
macrophage (Fig. 3C).
Hypoxia, hypoxia mimetic like cobalt chloride, iron chelation
and several other inducers promote HIF-1a expression by post-
translational stability mechanism [10]. Interestingly, we detected
only about 2-fold increase in HIF-1a mRNA in LD-infected J774
cells whereas about 4-fold increase in HIF-1a protein expression
(left upper panel) and Actin (left lower panel) were performed in nuclear extracts isolated from J774 cells infected by LD with different ratios of
multiplicity for 16 h. Right panel represents densitometric analysis from three independent experiments. C. Similar experiments were performed after
0, 8 and 24 h of infections with LD (MOI-1:10) and Western blot analyses were performed for HIF-1a (left upper panel) and HIF-1b (left lower panel).
Right panel represents densitometric analysis from three independent experiments. D. J774 cells was incubated with cytochalasin D (2 mM; CytoD)
60 min before LD infection and Western blot analysis was performed for HIF-1a (left upper panel) and lamin (left lower panel) in nuclear extracts
isolated after 8 h. Right panel represents densitometric analysis from three independent experiments.
doi:10.1371/journal.pone.0038489.g001
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hypothesize that LD-infection also might result into HIF-1a
stabilization in host cells. To verify this, we tested HIF-1a protein
stabilization during LD infection. After 6 h of infection, J774 cells
were treated with cycloheximide (5 mg/ml) and rate of HIF-1a
degradation was analyzed by Western blot analysis. The half-life of
HIF-1a in LD-infected cells was found close to 20 min; whereas,
half-life of HIF-1a was detected about 2 min in uninfected cells
(Fig. 4A-B) as reported earlier during normoxic condition [1].
Cobalt chloride was used as a positive control to verify HIF-1a
stabilization (Fig. 4A–B). These results suggest involvement of
HIF-1a stabilization as second mechanism of HIF-1 activation
during LD infection. Then, we determined PHD activity in LD
infected cells as cellular PHD activity was shown to inversely affect
HIF-1a stabilization [4,5]. Results showed LD infection decreased
the activity substantially like the positive control iron chelator
deferrioxamine (DFO) (Fig. 4C). Depletion of cellular iron is
known to affect prolyl hydroxylase activity in vitro and in vivo as iron
is an important cofactor of HIF-1a hydroxylation by prolyl
hydroxylases [25]. Recently, we demonstrated the unique ability of
intracellular LD to deplete iron from host labile iron pool (LIP)
[26] that could be the cause of decreased prolyl hydroxylase
activity. Determination of LIP in LD-infected J774 cells showed
a strong depletion of LIP than uninfected cells (Fig. 5A). Iron
chelator DFO was used as a positive control (Fig. 5A). To confirm
that decrease in PHD activity was actually due to depletion of LIP,
LD-infected cells were supplemented with physiological concen-
tration of holo-transferrin or apo-transferrin and cellular PHD
activity was determined. Decrease in PHD activity due to LD-
infection was reversed by supplementation of only holo-transferrin
but not by apo-transferrin (Fig. 5B). This experiment strongly
suggests that LD-induced depletion of LIP in host cells could affect
the PHD activity as supplementation of iron as holo-transferrin
could reverse it. Supplementation of either holo-transferrin or apo-
transferrin did not show any significant effect on PHD activity in
uninfected cells (data not shown). To verify whether cellular
oxygen level had any influence on decrease in LD-induced PHD
activity; we exposed cells to hypoxyprobe that is known to sense
decrease in cellular oxygen level. No signal with hypoxyprobe was
detected in LD-infected J774 cells (Fig. 5C); whereas, exposure of
cells to hypoxia (1.5%) showed strong signal with hypoxyprobe
suggesting cellular oxygen level was not altered due to LD
infection (Fig. 5C). Interestingly, a recent report showed PHD2
expression was affected in host cells due to infection of Toxoplasma
gondii [27]. When we tested PHD2 expression in LD-infected cells
no change was detected even after 16 h of infection (Fig. 5D). All
these results strongly suggest that LD activates HIF-1 in host
macrophage simultaneously by two distinct mechanisms involving
HIF-1a transcription as well as HIF-1a stabilization.
HIF-1 Activation is Beneficial for Intracellular LD
To find the role of HIF-1 on the outcome of LD infection; we
blocked HIF-1a expression in J774 cells using HIF-1a specific
siRNA. The increased expression of HIF-1a was significantly
blocked by the specific siRNA (HIF-1-KD); whereas, non-specific
siRNA (scRNA) showed no effect on HIF-1a expression (Fig. 6A).
The growth of intracellular LD was significantly inhibited in HIF-
1-KD J774 cells compared to scRNA transfected cells (Fig. 6B)
suggesting beneficial effect of HIF-1 activation on parasite within
host macrophage. When number of intracellular LD was counted
after 2 h of infection similar numbers of parasite were detected in
both the scRNA and siRNA transfected macrophages indicating
HIF-1 did not play any role in entry of the parasite but was
beneficial for survival in post-infective stage (Fig. 6B).
HIF-1a Overexpression Promotes Growth of Intracellular
LD
To further verify the role of HIF-1 in LD-infection in to host
macrophages; we over-expressed a stable mutant of HIF-1a (HIF-
1a P/A) in which pro
402 and pro
564 were mutated to alanine (kind
gift from Dr. Ritu Kulseshthra). We initially verified that
transfection of HIF-1a P/A cDNA actually resulted into increased
expression of HIF-1a by Western blot analysis (Fig. 7A, lane 2)
than untransfected cells (UT, Fig 7A, lane 1) or transfection of wild
type HIF-1a (Wild, Fig 7A, lane 3). Then in a similar condition
cells were infected with LD and the number of intracellular LD
was counted after 2 h, 12 h and 24 h. We detected a similar
number of intracellular LD after 2 h in untransfected, mutant and
wild type HIF-1a transfected cells suggesting that HIF-1a amount
has no role in infectivity of LD (Fig. 7B) as found in the previous
experiment. To further confirm that HIF-1a over-expression did
not influence phagocytosis mechanism, we performed phagocyto-
sis assay. In all cases (untransfected, mutant and wild-HIF-1a
transfected), a similar number of latex beads was detected within
macrophages (data not shown) further supporting that cellular
amount of HIF-1a had no influence on the initial infection rate of
LD. When intracellular LD was counted after 12 h in HIF-1a
over-expressed cells about 70% increase in intracellular LD was
detected compared to untransfected or wild-type HIF-1a trans-
fected cells. Higher growth of LD (about 25–30% compared to
untransfected or wild-HIF-1a transfected cells) could be observed
in HIF-1a over-expressed cells even after 24 h. Reduction in
comparable growth rate at 24 h compared to 12 h was probably
due to normal HIF-1 activation by LD-infection in untransfected
and wild-HIF-1a transfected cells that limited the advantage of
HIF-1a over-expression. These experiments further suggest HIF-
1a expression is beneficial for intracellular LD.
Discussion
Mechanism of HIF-1 activation and its role on the outcome of
infection of protozoan parasites in macrophage is less understood
Figure 2. LD promotes HIF-1a nuclear localization in macrophages in vitro and in vivo. A. J774 cells were infected with LD (MOI-1:10)
(lower panel) or remain uninfected (upper panel). After 6 h of infection indirect immunofluorescence assay was performed using HIF-1a antibody.
DAPI was used for nuclei staining of the host and intracellular LD (indicated by white arrows). In lower panel bigger and horizontal white arrow
represents the J774 cell that was not infected with LD. Result is representative of one of six independent experiments. B. Peritoneal macrophages
were isolated from BALB/c mice and infected with LD (MOI-1:10). After 6 h of infection indirect immunofluorescence assay was performed using HIF-
1a antibody. DAPI was used for nuclei staining of both the host and LD (indicated by white arrows). Result is representative of one of the four
independent experiments. C. Splenic macrophages were isolated from uninfected (-LD) or LD infected BALB/c mice (+ LD) and HIF-1a was detected
by indirect immunofluorescence assay using HIF-1a antibody. DAPI was used for detection of nuclei of both host and LD (indicated by white arrows).
D. Real-time RT-PCR was performed from total RNA isolated from splenic macrophages isolated from LD-infected or uninfected mice using specific
primers for HIF-1 target genes like VEGF, PAI-1, GLUT-1. b-actin was determined as a control. Results are representative of three independent
experiments in each of which total RNA was isolated from macrophages derived from spleen of three mice.
doi:10.1371/journal.pone.0038489.g002
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PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e38489Figure 3. Transcriptional activation of HIF-1a by LD infection. A. Northern analysis of HIF-1a was performed (left upper panel) with total RNA
isolated from LD infected (MOI-1:10) and LPS (1 mg/ml) treated J774 cells (8 h). 28S rRNA detected using ultraviolet served as loading control (left
lower panel). Right panel represents densitometric analysis from three independent experiments. B. Total RNA was isolated from spleen derived
macrophages from uninfected and LD-infected mice and real time RT-PCR was performed using either mouse HIF-1a (upper panel) or mouse b-actin
(lower panel) specific primers obtained from Applied Biosystems. Data is representative of one of the four different experiments (n=4). C. A luciferase
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infective pathogens, HIF-1 activation in host macrophage is
beneficial for survival of the parasite Leishmania donovani. Uniquely,
this parasite activates HIF-1 by two distinct mechanisms not
reported so far for any other pathogens. This implies a crucial role
of HIF-1 for the benefit of this intracellular pathogen.
In general, HIF-1 activation during infections caused by
Streptococcus pyogenes, Pseudomonas aeruginosa, Salmonella typhimurium
and several other bacteria promotes increased killing of these
pathogenic bacteria by modulating several innate immune
responses by the host [10,11]. For a few pathogens activation of
HIF-1 in host does not lead to their elimination as we detected for
LD in this study. Bartonella henselae exploits HIF-1 activation in host
cells by increasing VEGF expression for inducing angio-pro-
liferative disorders [28]. In general, viral infection is also contained
by HIF-1 activation. It was reported that HIF-1 activation by
hypoxia or pharmacological agents can suppress the cytolytic
injury and viral replication in infections mediated by vesicular
stomatitis virus (VSV) by activating TGF-b and other antiviral
genes [29]. On the contrary, HIF-1 activation fails to resolve
infections caused by hepatitis B and C viruses (HCV and HBV),
instead prolonged HIF-1 activation leads to VEGF mediated
neovascularization leading into the development of hepatocellular
carcinoma [30,31]. Interestingly, another protozoan parasite
Toxoplasma gondii activates HIF-1 in host cells by stabilizing HIF-
1a by suppressing PHD2 expression for its survival and growth
[27] but the precise role of HIF-1 in its survival is not clear yet.
Our study suggests that like T. gondii LD also exploits activation of
HIF-1 in mammalian host for its survival and growth. It will be
interesting to find whether all protozoan parasites use HIF-1 for
their advantage or only these two parasites are different than
others.
HIF-1 is activated mostly by HIF-1a stabilization by various
stimuli or by transcription during bacterial infection [10]. HIF-1a
transcription is detected as an essential mechanism of HIF-1
activation in response to inflammation and infection [9–11]. The
basal transcription of HIF-1a is dependent on NFkB [15]. In
response to LPS and bacterial infections NFkB binding to HIF-1a
promoter is further increased [14,15]. Amongst infection related
HIF-1 activation mechanism enterobacteriaceae infection causes
HIF-1a stabilization by secreting iron-chelating siderophore [32].
Respiratory syncytial virus (RSV) also activates HIF-1 in
pulmonary epithelia by an oxygen-independent mechanism [33];
however, exact mechanism of HIF-1 activation by RSV is not
clear so far. In this study, we observed that LD infection could
promote HIF-1a transcription (Fig. 3), although molecular
mechanism remained to be understood. NFkB is reported as the
main contributor of HIF-1a transcription by LPS treatment or
bacterial infection [13,14]. Moreover, several other physiological
stimuli like thrombin and reactive oxygen species generation could
activate NFkB for HIF-1a transcription [34]. There are conflicting
reports of NFkB activation in host cells during leishmanial
infection as increased NFkB activity was reported by both LD
infection and by its membrane component lipophosphoglycan
(LPG) [35]. In contrary, down regulation of NFkB activity was
also reported by LD infection [36]. It will be interesting to find the
precise molecular mechanism of HIF-1a transcription during LD
infection in macrophages that needs further study.
In this study we revealed that LD infection not only increased
HIF-1a transcription but also affected host PHD activity to
stabilize HIF-1a (Fig. 4A-C). The cellular PHD activity depends
on the availability of cofactors like oxygen or iron [4,5]. In an
earlier report we demonstrated that intracellular LD has a unique
ability to deplete labile iron pool (LIP) in host macrophage [26].
This is again confirmed in the current study by using iron-
sensitive fluorescence probe calcein-AM (Fig. 5A). It is well
known that depletion of cellular iron pool promotes binding of
iron sensors IRP1/IRP2 to iron responsive element (IRE). We
reported increased IRE-IRP binding in spleen derived macro-
phages of LD infected mice and J774 macrophages [26] strongly
suggesting depletion of host iron pool during LD-infection. To
confirm that depletion of iron pool in host by LD was actually
the cause of decreased PHD activity, we supplemented physio-
logical concentration of holo-transferrin or apo-transferrin after
LD infection and determined PHD activity. PHD activity was
reversed only by supplementation of holo-transferrin (Fig. 5B) but
not by similar concentration of apo-transferrin. To consider that
whether LD infection also could affect cellular oxygen level to
decrease PHD activity we performed experiments with hypoxyp-
robe. Hypoxyprobe is known to react in cellular hypoxic
condition as we detected in our experiment with 1.5% oxygen
(Fig. 5C). We were not able to detect any hypoxyprobe sensitivity
in host macrophage during LD infection suggesting the decrease
in PHD activity was only due to iron depletion but not due to
depletion of cellular oxygen level. A recent report demonstrated
that another protozoan parasite Toxoplasma gondii could stabilize
HIF-1a by decreasing PHD2 amount in the host cells [27].
Although, three HIF-1a prolyl hydroxylases (PHD1-3) have been
identified, gene knockout and siRNA studies suggested PHD2 as
primarily responsible for regulating HIF-1a [37]. In our
experiment we have not found any decrease in PHD2 protein
expression in macrophages by LD infection (Fig. 5D) unlike T.
gondii suggesting these two protozoan parasites suppress PHD
activity by distinctly different mechanisms to exploit benefit of
HIF-1 activation in host. Interestingly, the utilization of two
distinct mechanisms for HIF-1 activation simultaneously has not
been reported for any other infection so far.
We observed that like bacterial infection [10,11] HIF-1 has no
influence on rate of infection of LD as numbers of intracellular LD
were similar after 2 h of infection (Fig. 6B) for both HIF-1
containing and KD cells. Similarly, HIF-1a overexpressed cells did
not show any significant change in its phagocytic capacity (Fig. 7B).
So, the inability of LD growth in HIF-1KD cells depends on its
failure to exploit HIF-1-less host environment. Similarly, already
present HIF-1 in HIF-1a overexpressed cells provided advantage
for intracellular growth of the parasite. The current study does not
address the detail cellular mechanism(s) by which LD exploits
HIF-1 dependent cellular metabolism of host cells. LD resides and
proliferates within individual tight-fitting parasitophorous vacuoles
(PV) that contain variety of carbon sources and essential nutrients
but poor in hexose accumulation [19]. Previous report of inability
of growth and survival of glucose transporter mutants of L.
mexicana within macrophage [38] suggests that glucose acquisition
from host is essential for intracellular LD. Given the role of HIF-1
in glucose metabolism the intracellular alteration and utilization of
host glucose metabolism may be advantageous to LD. Our finding
of increased GLUT-1 expression in infected macrophages (Fig. 2D)
chimera with HIF-1a promoter and b-galactosidase with SV40 promoter constructs were transfected in J774 cells and either incubated with LPS
(1 mg/ml) or infected with LD (MOI-1:10). After 12 h luciferase and b-galactosidase activities were determined in cell lysates. Results were expressed as
SD of three independent experiments performed in triplicates after normalizing luciferase activity with b-galactosidase activity.
doi:10.1371/journal.pone.0038489.g003
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PLoS ONE | www.plosone.org 7 June 2012 | Volume 7 | Issue 6 | e38489Figure 4. LD infection promotes HIF-1a stability. A. J774 cells were infected with LD or remained uninfected or treated with hypoxia mimetic
cobalt chloride (100 mM) for 6 h and then cycloheximide (5 mg/ml) was added. Nuclear extracts were isolated after 0, 10, 20 and 30 min of
cycloheximide addition and Western blot analyses for HIF-1a and Actin were performed. B. Relative stabilization of HIF-1a was determined by
densitometric analysis of three independent experiments as described in ‘A’. C. Prolyl hydroxylase assay was performed as a measure of 2-OG
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activator inhibitor 1 (PAI-1), a HIF-1 target gene [39] is induced
by LD infection in infected macrophages (Fig. 2D). Since, PAI-1
can block apoptosis [40] and one of the survival strategies of
leishmania parasite within macrophages is to inhibit apoptosis
mechanism of host [41], LD induced PAI-1 by HIF-1 dependent
mechanism could be also another potential mechanism for its
intracellular survival advantage. There are close to 100 genes are
regulated by HIF-1 [42]; we consider LD may exploit several HIF-
1 target genes for its survival advantage. It needs a detailed study
to understand contributions of specific HIF-1 target genes those
are advantageous to intracellular LD.
Interestingly, HIF-1 activation is also responsible for increased
synthesis of immune effector molecules like nitric oxide, granule
proteases and antimicrobial peptides in phagocytes [11]. Thus, to
gain advantage from HIF-1 activation, the parasite should
neutralize these immune effector molecules. The unique ability
of leishmania to reside within acid rich phagolysosomal vesicles
[43] as well as to suppress nitric oxide generation may be crucial
for this balancing act [44]. When other invading pathogens are
falling prey of HIF-1 mediated immune responses, ability of
leishmania to suppress nitric oxide generation may be helpful to
exploit HIF-1 mediated alteration of host metabolism. Similarly,
when other pathogens are destroyed in lysosomal compartments
by acid rich environment and granule proteases, then leishmania
could survive by adopting with this extreme environment [43].
Soluble carrier family11, member A1 (SLC11A1, previously
known as NRAMP1), a protein-coupled divalent ion transporter
was the first infectious disease susceptibility gene identified, whose
allelic variation was reported to alter the risk of leishmaniasis [10].
Interestingly, HIF-1 regulates heritable variation and allele
expression phenotypes of SLC11A1 from a Z-DNA-forming
microsatellite [45]. Given the role of this proton efflux pump in
transport of divalent metal ions like Fe
2+ or Mn
2+ from lysosomal/
phagolysosomal compartment to cytosol, HIF-1 mediated
SLC11A1 expression should be detrimental to intracellular LD
growth; however, the parasite may overcome this condition by
expressing divalent metal ion transporter LIT-1 in its intracellular
form [46] during successful infection.
In summary, we found that unlike most of other pathogenic
organisms LD utilizes HIF-1 in infected macrophage in its favor
for its intracellular survival advantage. This is also the first
demonstration of HIF-1 activation by dual mechanism during any
intracellular infection. Finding HIF-1 inhibitors is an active area of
research because of its central role in angiogenesis and other
pathological conditions [47]. Rational design of such an inhibitor
thus could also be helpful in controlling this fatal intracellular
parasitic infection for which available drugs are mostly resistant.
Materials and Methods
Cell Culture
J774 A.1 macrophage cell line (J774) and RAW 264.7 were
from ATCC and maintained in RPMI-1640 (Sigma) medium
supplemented with 10% heat inactivated fetal bovine serum
(Hyclone) and 100 units/ml penicillin, 100 mg/ml streptomycin
(Sigma) in a humidified CO2 incubator at 37uC as described
earlier [26]. Peritoneal macrophages were isolated from BALB/c
mice after injecting 2 ml of 2% starch i.p. as described earlier [48].
Splenic macrophages were isolated from BALB/c female mice
following the procedure mentioned before [26] and cultured in
RPMI-1640 medium supplemented with 10% heat inactivated
fetal bovine serum (Hyclone), 100 units/ml penicillin and 100 mg/
ml streptomycin.
Animal
Ethics statement. BALB/c female mice 4–12 weeks old
were procured (National Centre for Laboratory Animal Sciences,
Hyderabad, India) and used for infection and propagation of the
virulent strain of Leishmania donovani AG83 as approved by the
Institutional Animal Ethics Committee-Jawaharlal Nehru Univer-
sity (Institutional Animal Ethics Committee Code No. 10/2004)
by passaging every 4 weeks.
After infection for 4 weeks spleens of BALB/c mice were
removed aseptically, homogenized under sterile conditions and
suspended in M199 with 30% FBS. This suspension was incubated
at 22uC for 48 to 72 hours. Freshly transformed promastigotes
were verified under the microscope and counted; the suspension
was centrifuged at 1000 rpm for 10 min at 4uC to remove splenic
debris and the promastigotes were centrifuged down at 5000 rpm
for 15 min at 4uC. The pellet was resuspended in PBS (pH 7.4) at
a concentration of 10
8 cells/ml. 100 ml of this freshly transformed
promastigotes was again injected in the tail vein of 2–4 weeks old
mice.
Parasite Culture and Maintenance
Leishmania donovani parasites in the promastigote stage were
maintained in M199 medium supplemented with 10% FBS
(Hyclone), 100 units/ml penicillin and 100 mg/ml streptomycin
(Sigma) at 22uC in a BOD incubator. To subculture a small
aliquot of the stationary phase parasite was added to fresh
medium.
Western Blot Analysis
Nuclear extract was prepared from J774 cells as described
earlier [24]. Briefly, 1 6 10
8 cells were washed with ice-cold
phosphate-buffered saline and then with a solution containing
10 mM Tris-HCl, pH 7.8, 1.5 mM MgCl2, and 10 mM KCl,
supplemented with a protease inhibitor mixture containing
0.5 mM dithiothreitol, 0.4 mM phenylmethylsulfonyl fluoride,
and 2 mg/ml each of leupeptin, pepstatin and aprotinin. After
incubation on ice for 10 min cells were lysed by 10 strokes with
a Dounce homogenizer and the nuclei were pelleted. The pellet
was resuspended in a solution containing 420 mM KCl, 20 mM
Tris-HCl, pH 7.8, 1.5 mM MgCl2, and 20% glycerol, supple-
mented with the protease mixture described above, and incubated
at 4uC with gentle agitation. The nuclear extract was centrifuged
at 10,0006g for 10 min, and the supernatant was dialyzed twice
against a solution of 20 mM Tris-HCl, pH 7.8, 100 mM KCl,
0.2 mM EDTA, and 20% glycerol. Protein concentration was
determined using the Bio-Rad reagent with bovine serum albumin
as standard. Proteins (30 mg) were subjected to electrophoresis and
transferred to PVDF membrane, incubated with anti HIF- 1a IgG
(1:2000; Novus Biologicals or Abcam), HIF-1b IgG (1:2000;
Novus Biologicals), PHD2 (1:2000; Abcam), actin (1:1000)
(SantaCruz) or lamin (1:1000) (SantaCruz) followed by peroxidase
conjugated secondary antibody (1:5000). The specific band was
detected by chemiluminescence using ECL reagent.
consumption in cytoplasmic extracts after 8 h of LD infection and DFO (100 mM) treatment. Result is expressed as standard deviation of four different
experiments.
doi:10.1371/journal.pone.0038489.g004
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PLoS ONE | www.plosone.org 9 June 2012 | Volume 7 | Issue 6 | e38489Figure 5. LD depletes cellular iron pool to block PHD activity. A. Labile iron pool was detected in untreated control and LD infected J774 cells
(6 h). DFO (100 mM) was used as positive control. B. After 8 h of LD infection apo-Tf (10 mM) and holo-Tf (10 mM) were added for 1 h and then PHD
activity was assayed. Result is expressed as standard deviation of four independent experiments. C. J774 cells were infected with LD or exposed to
hypoxia (1.5% O2) for 6 h and then incubated with 200 mM of pimonidazole hydrochloride (hypoxyprobe-1) for 2 h under similar conditions. Then
cells were fixed, washed and immunodetected with mAb to hypoxyprobe for visualization under fluorescence microscope. D. J774 cells were infected
with LD for 16 h and PHD2 (upper panel) and actin (lower panel) expressions were determined by Western blot analysis in cell extract. Result is
representative of one of the three independent experiments.
doi:10.1371/journal.pone.0038489.g005
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Total RNA was isolated using TriPure reagent (Roche) and
20 mg RNA was denatured in formamide/formaldehyde, electro-
phoresed through 1% agarose gel containing 6% formaldehyde
and blotted onto nylon membrane. After cross-linking, filters were
hybridized to HIF-1a cDNA (Novus Biologicals) labeled by
random priming with [a-
32P] dCTP using a New England Biolab
Kit.
Reverse Transcription Polymerase Chain Reaction
Analysis (RT)-PCR
Real-time RT-PCR (Applied Biosystem; 7500 Real Time PCR
System) was used to analyze transcripts levels of HIF-1a, VEGF,
PAI-1 and GLUT-1 in LD infected cells. Total RNA was insolated
using Tripure (Roche, Germany) to perform real-time RT-PCR.
cDNA was prepared using 5 mg of total RNA using High capacity
cDNA Reverse Transcription kit (Applied Biosystems, USA). Real
time RT-PCR for HIF-1a was performed using HIF-1a assay mix
(Mm01283760_m1 HIF-1a) procured from Applied Biosystem,
and results were normalized using actin as an endogenous control
[Mouse ACTB(20X) pre developed TaqManH Assay Reagents].
Program for HIF-1a amplification was 50uC- 2min; 95uC-
10 min; increasing cycles of (95uC - 15 sec; 60uC- 1 min). For
HIF-1a regulated genes VEGF, PAI-1 and GLUT-1 real time
RT-PCR was performed using Power SyBr Green PCR master
Mix (Applied Biosystem). The PCR reaction contained 30pM each
of Forward and Reverse primers of VEGF, PAI-1 and GLUT-1.
The following primers were used VEGF: For 59TAC TGC TGT
ACC TCC ACC ATG 39, Rev 59 CTT TCT CCG CTC TGA
ACA AG 39; PAI-1: For 59 AAA GGC ATA CCA AAG GTA TG
39, Rev 59 ACT TCA GTC TCC AGA GAG AAC 39; GLUT-1:
For 59 GGA TCC ATG ATG AAC CTG TTG 39, Rev 59 CTC
GAG GTG CAG GGT CCG TC 3. Results were normalized
using b-actin as endogenous control using following primers-
Forward 59 GAC TGG GAG AAG ATC 39 and Reverse 59 GAA
TGT AGT TTC ATG 39. The condition of amplification for
VEGF, PAI-1 and Glut-1 was 50uC - 2 min; 95uC-10 min;
increasing cycles of (95uC -15 sec, 54uC - 30 sec, 60uC-1 min).
HIF-1a Promoter and Other Construct Preparation
HIF-1a promoter region (–1034 to +339 of transcription start
site) was cloned by PCR from mouse genomic DNA using primers
containing Kpn1site in forward primer (59 ATA CAT GGT ACC
CAC GAA GTG TTC CTT TG 39) and Xho1site in reverse
primer (59 ATA CAT CTC GAG AAA GAG ACA AGT CCA
39). PCR fragment was cloned into upstream of pGL3 basic vector
and confirmed by sequencing. The cloning of functional hypoxia
responsive element of ceruloplasmin (CpHRE) and mutated
CpHRE (mutHRE) was described before [22].
Transfection and Reporter Gene Assay
In J774 cells transfection was performed (either CpHRE,
mutCpHRE or HIF-1a promoter construct) using Fugene 6
(Roche) according to company’s protocol. Transfected cells were
infected with LD. Luciferase activity in cell lysate was assayed
using a kit (Promega). As a control of transfection efficiency, cells
were also transfected with CMV promoter containing b-galacto-
sidase construct and assay was performed using a kit (Promega).
Results are expressed after normalization with b-galactosidase
activity.
Figure 6. HIF-1 activation is beneficial for intracellular LD. A.
Expression of HIF-1a was detected by Western blot analysis in LD
infected J774 cells (16 h) those were previously transfected with either
HIF-1a specific siRNA (siHIF-1a) or scrambled RNA (scHIF-1a). B.
Intracellular LD was isolated and counted at 2 h, 12 h and 24 h of LD
infection from siHIF-1a and scHIF-1a transfected J774 cells. Results are
representative of three independent experiments performed in
duplicates, P,0.06, ANOVA.
doi:10.1371/journal.pone.0038489.g006
Figure 7. Expression of stable form of HIF-1a promotes
intracellular LD growth. J774 cells were transfected with mutated
cDNA of HIF-1a (P/A) or wild type HIF-1a cDNA or remained
untransfected. Western blot analyses were performed in nuclear
extracts for HIF-1a (upper panel) or actin (lower panel). Result is
representative of one of the three independent experiments. B.
Intracellular LD in J774 cells was counted either after 2 h, 12 h or
24 h of infection in untransfected, mutated HIF-1a (P/A) or wild type
HIF-1a cDNA transfected cells. Results are representative of three
independent experiments performed in duplicates, P,0.05, ANOVA.
doi:10.1371/journal.pone.0038489.g007
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For immunofluorescence; LD infected J774, RAW264.7,
peritoneal macrophage or macrophages isolated from spleen of
age matched control and LD infected mice were fixed, after
blocking cells were incubated with primary antibody for 1 h at
room temperature. After washing secondary antibody coupled to
Cy 3 conjugate (1:1000) was used for 1 h at room temperature.
Antibody was used at following dilution: HIF-1a (1:1000). After
appropriate washing and mounting, cells were visualized under
a Zeiss Imager Z1 apotome microscope. Images were captured
using a cooled monochrome CCD camera AxioCam HRM using
Axiovision Rel 4.8.1 software.
Assessment of Calcein-sensitive Labile Iron Pool
Labile iron pool was assessed using Calcein-AM as described
earlier [26]. In short, LD infected J774 cells were washed with ice-
cold PBS and kept in RPMI-1640 (without phenol red). After
adding calcein-AM (0.5 mM) cells were incubated at 37uC for 20
minutes. Fluorescence microscopy was done at 488 nm excitation
and 517 nm emission. Nikon upright fluorescence microscope
model 80i equipped with water emersion objectives and connected
with cooled CCD digital camera was used for imaging.
Detection of Intracellular Hypoxic Condition by using
Hypoxyprobe
J774 cells were infected with LD (MOI- 1:10) for 8 h. Infected
cells were incubated with 200 mM of pimonidazole hydrochloride
(hypoxyprobe-1, Chemicon) for 2h. Cells were fixed with 4% para-
formaldehyde for 10 min and washed twice with 1x PBS. Non
specific binding was blocked by incubating cells with 1% BSA
solution prepared in 1x PBS. Cells were immunostained with
mouse monoclonal antibody (1:40) against pimonidazole adducts
for 1h at room temperature, followed by three washes with 1x
PBS. Then cells were further incubated with 1:1000 dilution of
Cy3 tagged anti-mouse secondary antibody followed by three
washes with 1x PBS. Cells were mounted over 10% glycerol
solution in 1xPBS and visualized under a Nikon Eclipse 80i
fluorescence microscope.
HIF-1a Silencing by siRNA
Silencing of HIF-1a in J774 cells was carried out by transfection
of cells with HIF-1a siRNA (from Qiagen, targeted sequence AAC
ACA CAG CGG AGC TTT TTT). Same sequence in scramble
(CAG AAC CGG ACA TTT AGC TTT) was used for control
transfection (HIF-1a scRNA). Two other HIF-1a specific siRNAs
from Santa Cruz Biotechnology (sc 44308 and sc 35562) were also
tested to silence HIF-1a expression. HIF-1a siRNA obtained from
Qiagen and sc44308 could block HIF-1a expression more than
80% and hence used for all related experiments. All the
transfections were carried out using company specific protocol
and reagents only. For HIF-1a siRNA (sc44308) transfection,
control scramble siRNA was also obtained (sc-37007) from Santa
Cruz Biotechnology.
Prolyl Hydroxylase Assay
Prolyl hydroxylase activity was determined by monitoring
depletion of 2-oxoglutarate by its post-incubation derivatization
with o-phenylenediamine to form a product amenable to
fluorescence analysis [34,49]. The assay was carried out by mixing
1 mM DTT, 0.6 mg/ml catalase, 2-oxoglutarate (2-OG,
500 mM), 200 mM peptide (19 mer of HIF-1a, 556–574,
DLDLEMLAPYIPMDDDFQL) and 50 mM Hepes pH 7.5 at
37uC for 5 min. The reaction was initiated by addition of cytosolic
extract (50 mg)/iron mix to the substrate/cofactor mix in a final
volume of 100 ml. After 5 min, 200 ml of 0.5 M HCl was added to
stop the reaction. Derivatization was achieved by addition of
100 ml of 10 mg/ml OPD in 0.5 M HCl for 10 min at 95uC. After
5 min centrifugation, supernatant (50 ml) was made basic by
adding 30 ml of 1.25M NaOH and then fluorescence was
measured using excitation at 340 nm and emission at 420 nm.
Counting of Intracellular Parasites
The intracellular parasites from J774 cells were counted using
percoll gradient as described earlier [26,50]. Briefly, infected
macrophages were lysed by 4 freeze-thaw cycles. Then cell lysates
were put in an individual percoll gradient (in the order of 90%,
40% and 20%) and spun at 800 xg for 1 hour. The band at the
interface of 90/40% percoll is collected and the volume of each
collection is equilibrated up to 1 ml. Parasites were counted in the
improved Neubaur Counting Chamber.
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